Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Res (Stuttg) ; 66(7): 377-83, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27191826

ABSTRACT

New 1-substituted-biguanide derivatives 1-3 were synthesized by the reaction of 2,4-dimethoxyaniline, hydrazine and methylhydrazine with dicyandiamide in diluted hydrochloric acid. The resulting biguanide salts were fully characterized by spectroscopic methods. The synthesized compounds were screened for their anti-diabetic activity with standard metformin drug. Oral treatment of hyperglycemic rats with the synthesized biguanide derivatives (200 mg/kg/day) for 2 weeks significantly decreased the elevated blood glucose level. Oral administration of biguanide derivative 2 significantly decreased the level of total cholesterol. While, the triglycerides level was little decreased following administration of biguanide 1 as compared to hyperglycemic rats. Additionally, anti-diabetic properties towards liver function enzyme activities (AST and ALT) and kidney functions (urea and critinine) as well as histopathological studies relative to metformin hydrochloride were investigated and discussed.


Subject(s)
Biguanides/chemistry , Biguanides/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Insulin Resistance , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Biguanides/chemical synthesis , Blood Glucose , Cholesterol/blood , Creatinine/urine , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/therapeutic use , Liver/pathology , Male , Metformin/therapeutic use , Rats , Rats, Wistar , Triglycerides/blood , Urea/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...